1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CECR6 CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA NFS1 CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA IL18 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA CEP131 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA ZNF682 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA CPT1C CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA C16orf92 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA FANCC CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA KIF5C CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA ITGB1 CTRPv2 pan-cancer AAC -0.16 1e-05
Download CSV